Pfizer Q2 adj. EPS 78 cents vs. 80 cents a year ago; FactSet consensus 67 cents

Pfizer Q2 EPS 61 cents vs. 89 cents a year ago

Pfizer Q2 biopharma revenue up 4% to $9.80 bln

Pfizer Q2 revenue $11.80 bln vs. $13.26 bln a year ago; FactSet consensus $11.58 bln

Pfizer raised 2020 adj. EPS outlook to $2.85-$2.95 from $2.82-$2.92

Pfizer Q2 Upjohn revenue down 32% to $2.01 bln

